Capital Research Global Investors Portfolio holdings
Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.
Top Buys
| 1 |
JPMorgan Chase
JPM
|
$1.17B |
| 2 |
Vale
VALE
|
$925M |
| 3 |
Microsoft
MSFT
|
$891M |
| 4 |
Comcast
CMCSA
|
$851M |
| 5 |
Micron Technology
MU
|
$788M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$3.19B |
| 2 |
AbbVie
ABBV
|
$1.92B |
| 3 |
Broadcom
AVGO
|
$1.22B |
| 4 |
UnitedHealth
UNH
|
$1.08B |
| 5 |
United Parcel Service
UPS
|
$985M |
Sector Composition
| 1 | Technology | 18.99% |
| 2 | Healthcare | 15.55% |
| 3 | Communication Services | 13.77% |
| 4 | Consumer Discretionary | 13.26% |
| 5 | Financials | 10.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
401
HUTCHMED
HCM
$2.58B
| $15.3M | ﹤0.01% | 541,645 -590,355 | -52% | -$16.7M |
|
|
LHDX
402
DELISTED
Lucira Health, Inc. Common Stock
LHDX
| $13.5M | ﹤0.01% | +1,115,416 | New | +$13.5M |
|
403
StepStone Group
STEP
$4.87B
| $12.6M | ﹤0.01% | 356,600 +62,500 | +21% | +$2.2M |
|
404
Cardlytics
CDLX
$54.3M
| $11M | ﹤0.01% | 100,000 | – | – |
|
|
ATVI
405
DELISTED
Activision Blizzard Inc.
ATVI
| $10.5M | ﹤0.01% | 113,165 -4,440,897 | -98% | -$413M |
|
406
Curtiss-Wright
CW
$18B
| $9.43M | ﹤0.01% | 79,500 | – | – |
|
407
Allegro MicroSystems
ALGM
$5.71B
| $9.42M | ﹤0.01% | 371,700 -928,300 | -71% | -$23.5M |
|
|
GWPH
408
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $9.05M | ﹤0.01% | 41,719 -3,694,490 | -99% | -$801M |
|
409
Qualcomm
QCOM
$173B
| $9.03M | ﹤0.01% | 68,099 +63 | +0.1% | +$8.35K |
|
|
AIFU
410
AIFU Inc. Class A Ordinary Share
AIFU
$67.5M
| $8.69M | ﹤0.01% | 623,758 -296,284 | -32% | -$4.13M |
|
411
Viavi Solutions
VIAV
$2.52B
| $6.84M | ﹤0.01% | +435,697 | New | +$6.84M |
|
412
ASML
ASML
$292B
| $5.25M | ﹤0.01% | 8,729 +1,032 | +13% | +$621K |
|
|
AMED
413
DELISTED
Amedisys
AMED
| $4.55M | ﹤0.01% | 17,200 | – | – |
|
414
Cenovus Energy Inc. Warrants (each warrant entitles the holder to purchase one common share at an exercise price of C$6.54 per share)
CVE.WS
$41.9M
| $4.25M | ﹤0.01% | +1,067,579 | New | +$4.25M |
|
|
HUIZ
415
Huize Holding Ltd
HUIZ
| $3.57M | ﹤0.01% | 426,459 -623,541 | -59% | -$5.22M |
|
416
NCR Voyix
VYX
$1.82B
| $3.55M | ﹤0.01% | +93,500 | New | +$3.55M |
|
417
Barclays
BCS
$68.9B
| $2.91M | ﹤0.01% | 280,403 +46,928 | +20% | +$486K |
|
418
Ares Management
ARES
$39.3B
| $2.56M | ﹤0.01% | 45,670 | – | – |
|
419
Alcoa
AA
$8.33B
| $902K | ﹤0.01% | 27,753 | – | – |
|
420
TSMC
TSM
$1.2T
| $616K | ﹤0.01% | 5,345 +934 | +21% | +$108K |
|
421
Vanguard FTSE All-World ex-US ETF
VEU
$48.6B
| $437K | ﹤0.01% | +7,194 | New | +$437K |
|
422
iShares MSCI ACWI ETF
ACWI
$22B
| $416K | ﹤0.01% | 4,385 +1,384 | +46% | +$131K |
|
423
Rio Tinto
RIO
$102B
| $415K | ﹤0.01% | 5,328 +2,681 | +101% | +$209K |
|
424
SPDR S&P 500 ETF Trust
SPY
$658B
| $394K | ﹤0.01% | 999 -726 | -42% | -$286K |
|
|
CMLS
425
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $307K | ﹤0.01% | 33,691 | – | – |
|